COVID–19 Emergency Medical Supplies Enhancement Act of 2020
Latest action · May 13, 2020 Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 13, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
COVID-19 Emergency Medical Supplies Enhancement Act of 2020
This bill expands certain authorities under the Defense Production Act of 1950 and directs the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies.
Cosponsors 8
Members who signed on, in the order they did. Signatures ran from May 13, 2020 to Sep 14, 2020; 5 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MI | Elissa Slotkin | Original | May 13, 2020 |
| D-CO | Jason Crow | Original | May 13, 2020 |
| D-MA | Lori Trahan | Original | May 13, 2020 |
| D-CA | Maxine Waters | Original | May 13, 2020 |
| D-OH | Tim Ryan | Original | May 13, 2020 |
| D-PA | Chrissy Houlahan | May 14, 2020 | |
| D-CA | Katie Porter | May 14, 2020 | |
| D-WA | Pramila Jayapal | Sep 14, 2020 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Financial Services Committee | Referred May 13, 2020 |
| House | Energy and Commerce Committee | Referred May 13, 2020 |
Actions 2
Everything that happened, newest first.
- May 13, 2020Introduced in House
- May 13, 2020Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 90, May 13, 2020, page H1999.
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46628 | COVID-19 and Domestic PPE Production and Distribution: Issues and Policy Options Archived | Report | Dec 7, 2020 |
| R46507 | FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19 Archived | Report | Sep 1, 2020 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 6395 | William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 | Related bill | Jan 2, 2021 |
| HR 6800 | The Heroes Act | Related bill | Jul 23, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To enhance authorities under the Defense Production Act of 1950 to respond to the COVID-19 emergency, to provide additional oversight of such authorities, and to require a strategy on securing supply chains for medical materials, and for other purposes.
- Short Title(s) as Introduced
- COVID–19 Emergency Medical Supplies Enhancement Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Government Operations and Politics.
- Blood and blood diseases
- Cardiovascular and respiratory health
- Congressional oversight
- Congressional tributes
- Department of Homeland Security
- Disability and paralysis
- Drug safety, medical device, and laboratory regulation
- Emergency medical services and trauma care
- Federal Emergency Management Agency (FEMA)
- Federal officials
- Government information and archives
- Government Operations and Politics
- Government studies and investigations
- Health facilities and institutions
- Health personnel
- Health programs administration and funding
- Health promotion and preventive care
- Health technology, devices, supplies
- Immunology and vaccination
- Indian social and development programs
- Industrial facilities
- Infectious and parasitic diseases
- Manufacturing
- Materials
- Medical tests and diagnostic methods
- Military procurement, research, weapons development
- Minority and disadvantaged businesses
- Minority health
- Public contracts and procurement
- Public-private cooperation
- Small business
- Strategic materials and reserves
- Veterans' education, employment, rehabilitation
- Women in business
- Worker safety and health
Text 1
Each version as it was printed, newest first.
- May 13, 2020Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.